Clinical Trial Update: A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals. [Phase 2]

View source ↗

Summary

Phase II/III trial investigating a rifampin-containing regimen for disseminated Mycobacterium avium complex infection in HIV-infected individuals has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Mycobacterium Avium Complex Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Mycobacterium Avium-intracellulare Infection, HIV Infections | Phase 2 | Status: COMPLETED